Prothena Corp Public (PRTA) Current Assets (2012 - 2026)
Prothena Corp Public (PRTA) posted quarterly Current Assets of $339.2 million for Q1 2026, down 22.23% year-over-year from $436.2 million in Q1 2025, and up 7.62% quarter-over-quarter from $315.2 million in Q4 2025.
Prothena Corp Public (PRTA) Current Assets (2012 - 2026) Analysis & Trends
Prothena Corp Public's Current Assets history runs 15 years deep, the most recent figure standing at $339.2 million for Q1 2026.
- In Q1 2026, Current Assets fell 22.23% year-over-year to $339.2 million; the TTM figure through Mar 2026 stood at $339.2 million (down 22.23% YoY), while the FY2025 annual figure was $315.2 million, down 35.07% from the prior year.
- Current Assets for Q1 2026 stood at $339.2 million, up from $315.2 million in the prior quarter.
- The five-year high for Current Assets was $719.1 million in Q4 2022, with the low at $315.2 million in Q4 2025.
- The 5-year median for Current Assets is $535.0 million (2024), against an average of $530.4 million.
- The sharpest annual moves came in 2022 and 2025: Current Assets jumped 57.71% in 2022, then tumbled 36.45% in 2025.
- Prothena Corp Public's Current Assets stood at $719.1 million in 2022, then decreased by 11.1% to $639.3 million in 2023, then declined by 24.07% to $485.4 million in 2024, then plunged by 35.07% to $315.2 million in 2025, then climbed by 7.62% to $339.2 million in 2026.
- Business Quant data shows PRTA's Current Assets at $339.2 million in Q1 2026, $315.2 million in Q4 2025, and $340.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 8.07 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 4.03 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 7.22 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 11.83 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 1.76 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 4.62 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.63 Bn |
| 10 | Prothena Corp Public | 458.45 Mn | 170.25 Mn | - | 292.01 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 292.01 Mn |
| Mar 31, 2026 | 339.20 Mn |
| Dec 31, 2025 | 315.19 Mn |
| Sep 30, 2025 | 339.97 Mn |
| Jun 30, 2025 | 385.48 Mn |
| Mar 31, 2025 | 436.17 Mn |
| Dec 31, 2024 | 485.41 Mn |
| Sep 30, 2024 | 534.98 Mn |
| Jun 30, 2024 | 585.98 Mn |
| Mar 31, 2024 | 565.87 Mn |
| Dec 31, 2023 | 639.28 Mn |
| Sep 30, 2023 | 690.60 Mn |
| Jun 30, 2023 | 677.10 Mn |
| Mar 31, 2023 | 700.34 Mn |
| Dec 31, 2022 | 719.10 Mn |
| Sep 30, 2022 | 524.56 Mn |
| Jun 30, 2022 | 521.29 Mn |
| Mar 31, 2022 | 555.62 Mn |
| Dec 31, 2021 | 584.81 Mn |
| Sep 30, 2021 | 607.53 Mn |